Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Growth hormone plasma levels in nonalcoholic fatty liver disease.

Literature DB >> 12003400

Growth hormone plasma levels in nonalcoholic fatty liver disease.

Amedeo Lonardo, Paola Loria, Francesca Leonardi, Dorval Ganazzi, Nicola Carulli.

Abstract

Entities: Disease Gene

Mesh：

Substances：
Growth Hormone

Year: 2002 PMID： 12003400 DOI： 10.1111/j.1572-0241.2002.05641.x

Source DB: PubMed Journal: Am J Gastroenterol ISSN： 0002-9270 Impact factor: 10.864

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

1. Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease.

Authors: Tatsuki Ichikawa; Kazuhiko Nakao; Keisuke Hamasaki; Ryuji Furukawa; Shotarou Tsuruta; Yasuo Ueda; Naota Taura; Hidetaka Shibata; Masumi Fujimoto; Kan Toriyama; Katsumi Eguchi
Journal: Hepatol Int Date: 2007-06-01 Impact factor: 6.047

2. The GH/IGF-1 Axis Is Associated With Intrahepatic Lipid Content and Hepatocellular Damage in Overweight/Obesity.

Authors: Laura E Dichtel; Kathleen E Corey; Melanie S Haines; Mark L Chicote; Allison Kimball; Caitlin Colling; Tracey G Simon; Michelle T Long; Jad Husseini; Miriam A Bredella; Karen K Miller
Journal: J Clin Endocrinol Metab Date: 2022-08-18 Impact factor: 6.134

Growth hormone plasma levels in nonalcoholic fatty liver disease.

1. Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease.

2. The GH/IGF-1 Axis Is Associated With Intrahepatic Lipid Content and Hepatocellular Damage in Overweight/Obesity.

Review 3. Growth Hormone and Insulin-Like Growth Factor 1 Regulation of Nonalcoholic Fatty Liver Disease.

Review 4. Endocrine and liver interaction: the role of endocrine pathways in NASH.

5. The Association Between IGF-1 Levels and the Histologic Severity of Nonalcoholic Fatty Liver Disease.

Review 6. Pituitary stalk interruption syndrome and liver changes: From clinical features to mechanisms.

Review 7. Nonalcoholic Fatty Liver Disease and Endocrine Axes-A Scoping Review.

8. Disruption of JAK2 in adipocytes impairs lipolysis and improves fatty liver in mice with elevated GH.

9. Panhypopituitarism due to Absence of the Pituitary Stalk: A Rare Aetiology of Liver Cirrhosis.